Featured article

Preclinical safety analysis using Artificial Intelligence on the example of Alzheimer’s Disease.

Causaly AI enables researchers to identify safety-relevant information in medical literature regarding a drug candidate. Preclinical experts can include this data in the preclinical study design to minimize the risks of unforeseen toxicities and increase chances of approval.

Sign up for Causaly newsletter